Sotac Pharma.

{
  "main_header": {
    "sid": 1003827,
    "name": "Sotac Pharma.",
    "stock_name": "Sotac Pharma.",
    "full_name": "Sotac Pharmaceuticals Ltd",
    "name_url": "stocks-analysis/sotac-pharma",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "125.00",
    "chg": "0.00",
    "chgp": "0.00%",
    "dir": 0,
    "prev_price": "125.00",
    "mcapval": "138.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": "",
    "symbol": "SOTAC",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE0O2D01012",
    "curr_date": "Feb 13",
    "curr_time": "",
    "bse_nse_vol": 1200,
    "exc_status": "Active",
    "traded_date": "Feb 13, 2026",
    "traded_date_str": "2026 02 13",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/sotac-pharma-1003827-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3830339",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SotacPharmaceut_stocks_hitting_upper_circuit_3830339.png",
        "date": "2026-02-10 10:01:16",
        "description": "Sotac Pharmaceuticals Ltd witnessed a remarkable surge on 10 Feb 2026, hitting its upper circuit limit of ₹124.20, marking a maximum daily gain of 4.99%. This sharp price movement was driven by robust buying interest, resulting in a regulatory trading freeze and highlighting significant unfilled demand in the micro-cap pharmaceutical stock."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-3828526",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SotacPharmaceut_mojoScore_3828526.png",
        "date": "2026-02-09 10:10:30",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 January 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 February 2026, providing investors with the latest perspective on the company’s position."
      },
      {
        "title": "Sotac Pharmaceuticals Gains 12.67%: 2 Key Events Shaping the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-gains-1267-2-key-events-shaping-the-week-3812379",
        "imagepath": "",
        "date": "2026-01-31 10:04:02",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>Jan 27:</strong> Sotac Pharmaceuticals hits upper circuit at Rs.110.25 (+5.00%) amid strong buying pressure</p>\n                    <p><strong>Jan 28:</strong> Stock price remains steady at Rs.110.25 with Sensex rallying 1.12%</p>\n                    <p><strong>Jan 29:</strong> Sotac plunges to lower circuit at Rs.102.20 (-7.30%) amid heavy selling pressure</p>\n                    <p><strong>Jan 30:</strong> Stock rebounds sharply to close at Rs.118.30 (+4.78%)</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.105.00</div></div>\n                    <div cl..."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3809509",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SotacPharmaceut_stocks_hitting_lower_circuit_3809509.png",
        "date": "2026-01-29 11:00:15",
        "description": "Sotac Pharmaceuticals Ltd witnessed a sharp decline on 29 Jan 2026, hitting its lower circuit limit as intense selling pressure gripped the stock. The micro-cap pharmaceutical firm recorded a maximum daily loss of 7.30%, significantly underperforming its sector and the broader market, amid signs of panic selling and unfilled supply at the lower price band."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-3809334",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SotacPharmaceut_mojoScore_3809334.png",
        "date": "2026-01-29 10:10:29",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3806169",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SotacPharmaceut_stocks_hitting_upper_circuit_3806169.png",
        "date": "2026-01-27 14:00:08",
        "description": "Sotac Pharmaceuticals Ltd surged to hit its upper circuit limit on 27 Jan 2026, registering a maximum daily gain of 5.0% amid robust buying interest. The stock closed at ₹110.25, marking a significant outperformance against its sector and broader market indices despite subdued investor participation and regulatory trading restrictions."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-hits-upper-circuit-amid-strong-buying-pressure-3801947",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SotacPharmaceut_stocks_hitting_upper_circuit_3801947.png",
        "date": "2026-01-23 14:00:10",
        "description": "Sotac Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit of ₹105.00 on 23 Jan 2026, registering a maximum daily gain of 5.0%. This sharp rally was driven by robust buying interest, resulting in a regulatory freeze on further transactions and leaving a significant unfilled demand in the market."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/sotac-pharmaceuticals-ltd-is-rated-strong-sell-3783042",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SotacPharmaceut_mojoScore_3783042.png",
        "date": "2026-01-06 10:10:43",
        "description": "Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing."
      },
      {
        "title": "Sotac Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/sotac-pharmaceuticals-ltd-plunges-to-lower-circuit-amid-heavy-selling-pressure-3776448",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SotacPharmaceut_stocks_hitting_lower_circuit_3776448.png",
        "date": "2025-12-31 12:00:12",
        "description": "Sotac Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 31 Dec 2025, hitting its lower circuit limit with a maximum daily loss of 4.98%. The stock closed at ₹123.10, down ₹6.45 from the previous close, reflecting intense selling pressure and panic among investors amid unfilled supply on the trading floor."
      }
    ],
    "total": 318,
    "sid": "1003827",
    "stock_news_url": "https://www.marketsmojo.com/news/sotac-pharmaceuticals-1003827"
  },
  "announcements": "",
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Sotac Pharmaceuticals Ltd has declared <strong>1%</strong> dividend, ex-date: 19 Sep 25",
          "dt": "2025-09-19",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-02-10 10:01:16

Sotac Pharmaceuticals Ltd witnessed a remarkable surge on 10 Feb 2026, hitting its upper circuit limit of ₹124.20, marking a maximum daily gain of 4.99%. This sharp price movement was driven by robust buying interest, resulting in a regulatory trading freeze and highlighting significant unfilled demand in the micro-cap pharmaceutical stock.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-02-09 10:10:30

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 January 2026, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are current as of 09 February 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Sotac Pharmaceuticals Gains 12.67%: 2 Key Events Shaping the Week

2026-01-31 10:04:02

Key Events This Week

Jan 27: Sotac Pharmaceuticals hits upper circuit at Rs.110.25 (+5.00%) amid strong buying pressure

Jan 28: Stock price remains steady at Rs.110.25 with Sensex rallying 1.12%

Jan 29: Sotac plunges to lower circuit at Rs.102.20 (-7.30%) amid heavy selling pressure

Jan 30: Stock rebounds sharply to close at Rs.118.30 (+4.78%)

Week Open

Rs.105.00

Read full news article

Sotac Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2026-01-29 11:00:15

Sotac Pharmaceuticals Ltd witnessed a sharp decline on 29 Jan 2026, hitting its lower circuit limit as intense selling pressure gripped the stock. The micro-cap pharmaceutical firm recorded a maximum daily loss of 7.30%, significantly underperforming its sector and the broader market, amid signs of panic selling and unfilled supply at the lower price band.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-01-29 10:10:29

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 29 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.

Read full news article

Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-01-27 14:00:08

Sotac Pharmaceuticals Ltd surged to hit its upper circuit limit on 27 Jan 2026, registering a maximum daily gain of 5.0% amid robust buying interest. The stock closed at ₹110.25, marking a significant outperformance against its sector and broader market indices despite subdued investor participation and regulatory trading restrictions.

Read full news article

Sotac Pharmaceuticals Ltd Hits Upper Circuit Amid Strong Buying Pressure

2026-01-23 14:00:10

Sotac Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, surged to hit its upper circuit limit of ₹105.00 on 23 Jan 2026, registering a maximum daily gain of 5.0%. This sharp rally was driven by robust buying interest, resulting in a regulatory freeze on further transactions and leaving a significant unfilled demand in the market.

Read full news article

Sotac Pharmaceuticals Ltd is Rated Strong Sell

2026-01-06 10:10:43

Sotac Pharmaceuticals Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market standing.

Read full news article

Sotac Pharmaceuticals Ltd Plunges to Lower Circuit Amid Heavy Selling Pressure

2025-12-31 12:00:12

Sotac Pharmaceuticals Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, witnessed a sharp decline on 31 Dec 2025, hitting its lower circuit limit with a maximum daily loss of 4.98%. The stock closed at ₹123.10, down ₹6.45 from the previous close, reflecting intense selling pressure and panic among investors amid unfilled supply on the trading floor.

Read full news article

View All News